0001562180-24-004774.txt : 20240606 0001562180-24-004774.hdr.sgml : 20240606 20240606181353 ACCESSION NUMBER: 0001562180-24-004774 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240605 FILED AS OF DATE: 20240606 DATE AS OF CHANGE: 20240606 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Madden Martin J. CENTRAL INDEX KEY: 0001696864 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37565 FILM NUMBER: 241026673 MAIL ADDRESS: STREET 1: C/O MICROBOT MEDICAL INC. STREET 2: 175 DERBY STREET 27/1 CITY: HINGHAM STATE: MA ZIP: 02043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NovoCure Ltd CENTRAL INDEX KEY: 0001645113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF BUSINESS PHONE: 44 (0)15 3475 6700 MAIL ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF FORMER COMPANY: FORMER CONFORMED NAME: Novocure Ltd DATE OF NAME CHANGE: 20150615 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2024-06-05 false 0001645113 NovoCure Ltd NVCR 0001696864 Madden Martin J. C/O NOVOCURE INC. 1550 LIBERTY RIDGE DRIVE, SUITE 115 WAYNE PA 19087 true false false false false Ordinary Shares 2024-06-05 4 A false 4053.00 0.00 A 19673.00 D Stock Option (Right to Buy) 23.13 2024-06-05 4 A false 6229.00 0.00 A 2034-06-04 Ordinary Shares 6229.00 6229.00 D These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2025 annual general meeting of shareholders. Report no longer includes indirect ownership of shares held by filer's adult child. Child no longer shares a residence with the filer. Options to buy 6,229 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2025 annual general meeting of shareholders. Ovie Onobrakpeya, as attorney in fact for Madden, Martin J. 2024-06-06